Skip to content

The Edge of the Cyber World See the latest

Technology

Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent

Revolution Medicines attracted takeover interest but decided to go it alone. This week’s FDA approval of its pancreatic cancer pill is the payoff.